transrectal ultrasound-guided biopsy

transrectal ultrasound-guided biopsy

diagnostic procedure used to assess prostatic nodules for evidence of malignancy.
Mentioned in ?
References in periodicals archive ?
A mathematical model was used by a team of researchers from leading universities in Belgium and the Netherlands to evaluate diagnostic strategies using SelectMDx versus PSA testing alone, to identify patients for transrectal ultrasound-guided biopsy (TRUSGB) procedures.
Outbreak of fluoroquinolone-resistant Escherichia coli infections after transrectal ultrasound-guided biopsy of the prostate.
The effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate.
After phlebotomy, the men underwent at least a 10-core transrectal ultrasound-guided biopsy.
Following phlebotomy, the men underwent at least a 10-core transrectal ultrasound-guided biopsy.
While multiparametric prostate MRI is not currently used as a first-line tool for diagnosing prostate cancer, it has proven very helpful for directing targeted biopsies, particularly in select men like our patient with persistent, elevated PSA levels, and a previous negative transrectal ultrasound-guided biopsy.
When a transrectal ultrasound-guided biopsy was performed in the 71 men who did not have prostatitis, 36 were found to have prostate cancer.
A 67-year-old man, with a history of chronic obstructive pulmonary disease and benign prostatic hyperplasia, was diagnosed with adenocarcinoma of the prostate after a transrectal ultrasound-guided biopsy of the prostate.
In patients in whom prostate cancer is suspected, a 10-12 core transrectal ultrasound-guided biopsy of the prostate is warranted.